Leading healthcare service providers

领先的医疗服务提供商

Aster DM Healthcare

阿斯特DM医疗保健

has completed acquisition of 5% stake in

已完成收购5%的股份

Quality Care India

印度优质护理

Ltd (QCIL) from BCP Asia II TopCo IV Pte Ltd (BCP) and Centella Mauritius Holdings Limited (Centella) through a share swap.

通过股份交换，从BCP亚洲II TopCo IV私人有限公司（BCP）和Centella毛里求斯控股有限公司（Centella）获得。

#Pahalgam Terrorist Attack

#帕哈尔甘恐怖袭击

PM Modi-led 'Super Cabinet' reviews J&K security arrangements

莫迪总理领导的“超级内阁”审查了查谟和克什米尔的安全安排。

Pakistan's General Asim Munir is itching for a fight. Are his soldiers willing?

巴基斯坦的阿西姆·穆尼尔将军渴望一战。他的士兵们愿意吗？

India planning to launch military strike against Pakistan within 24 to 36 hours, claims Pak minister

巴基斯坦部长声称，印度计划在24至36小时内对巴基斯坦发动军事打击

The acquisition is the first step towards the strategic merger between

此次收购是朝着战略合并迈出的第一步

Aster DM Healthcare

阿斯特DM医疗保健

and Quality Care India announced in November,

印度质量和护理部门于十一月宣布，

Aster

紫菀

DM said in a press statement on Wednesday. The merger is expected to be completed this year.

国防部在周三的新闻发布会上表示，预计合并将在今年完成。

The transaction was completed by acquiring 1,90,46,028

该交易通过收购1,90,46,028股完成。

equity shares

股票

of QCIL by Aster DM Healthcare from BCP and TPG for a value of Rs 849.13 crore. As discharge of the total purchase consideration payable, Aster DM Healthcare has allotted 1,86,07,969 equity shares (face value Rs 10 each) to BCP and Centella.

Aster DM Healthcare从BCP和TPG手中以8.4913亿卢比的价值收购了QCIL。作为支付总价款的一部分，Aster DM Healthcare已向BCP和Centella分配了18,607,969股股权（每股面值10卢比）。

The share swap has been undertaken pursuant to receipt of necessary approvals, including shareholder consent, in-principle approval from BSE and NSE, and CCI approval and is subject to the final listing and trading approval from BSE and NSE for the new equity shares allotted to BCP and Centella by Aster, the statement noted..

该声明指出，股份置换已经过必要审批，包括股东同意、孟买证券交易所（BSE）和印度国家证券交易所（NSE）的原则性批准以及印度竞争委员会（CCI）的批准，并需等待BSE和NSE对Aster向BCP和Centella分配的新股权的最终上市和交易批准。

Dr Azad Moopen, Founder Chairman, Aster DM Healthcare said: “The acquisition of 5% stake in QCIL through a share swap is the first step towards the strategic merger between Aster DM Healthcare and QCIL.”

阿扎德·穆普恩，阿斯特DM医疗保健公司的创始人兼董事长表示：“通过股票互换收购QCIL 5%的股份是阿斯特DM医疗保健公司与QCIL战略合并的第一步。”

Live Events

现场活动

“This move lays the foundation for a unified, future-ready

“此举为统一、面向未来奠定了基础

healthcare network

医疗保健网络

with a strengthened pan-India presence. As we progress toward full integration, our focus remains firm towards creating significant long-term value for all our stakeholders,” Moopen added.

随着我们在全印度的业务不断加强，Moopen补充道：“在我们迈向全面整合的过程中，我们的重点仍然是为所有利益相关者创造显著的长期价值。

The newly issued shares will have equal rights with existing equity shares of Aster.

新发行的股份将与Aster现有的股权享有同等权利。

The merged entity (subject to approvals) ‘

合并后的实体（须经批准）‘

Aster DM Quality Care

阿斯特DM质量护理

’ will be jointly controlled by Aster promoters and BCP.

’将由Aster的发起人和BCP共同控制。

(You can now subscribe to our

（您现在可以订阅我们的

Economic Times WhatsApp channel

经济时报 WhatsApp 频道

)

)

(You can now subscribe to our

（您现在可以订阅我们的

Economic Times WhatsApp channel

经济时报WhatsApp频道

)

)